Reducing Heterogeneity in OA Clinical Trials: Data from a Phase 2 Study of SM04690, a Novel, Intra-Articular, Wnt Pathway Inhibitor in Knee Osteoarthritis

被引:0
|
作者
Conaghan, Philip G. [1 ]
DiFrancesco, Anita [2 ]
Swearingen, Christopher J. [2 ]
Kennedy, Sarah [2 ]
Simsek, Ismail [2 ]
Tambiah, Jeymi [2 ]
Yazici, Yusuf [2 ]
机构
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Samumed LLC, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1201
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Safety, Efficacy and Biomarker Outcomes of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee: Interim, Exploratory Analysis of Results from a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
    Yazici, Yusuf
    McAlindon, Timothy E.
    Fleischmann, Roy
    Gibofsky, Allan
    Lane, Nancy E.
    Kivitz, Alan J.
    Skrepnik, Nebojsa
    Armas, Eddie
    Swearingen, Christopher J.
    DiFrancesco, Anita
    Tambiah, Jeyanesh R. S.
    Hood, John
    Hochberg, Marc C.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [42] A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee
    Deshmukh, V.
    Hu, H.
    Barroga, C.
    Bossard, C.
    Kc, S.
    Dellamary, L.
    Stewart, J.
    Chiu, K.
    Ibanez, M.
    Pedraza, M.
    Seo, T.
    Do, L.
    Cho, S.
    Cahiwat, J.
    Tam, B.
    Tambiah, J. R. S.
    Hood, J.
    Lane, N. E.
    Yazici, Y.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 (01) : 18 - 27
  • [43] ANTI-INFLAMMATORY PROPERTIES OF SM04690, A SMALL MOLECULE INHIBITOR OF THE WNT PATHWAY AS A POTENTIAL TREATMENT FOR KNEE OSTEOARTHRITIS
    Deshmukh, V.
    Barroga, C.
    Ibanez, M.
    Seo, T.
    Kc, S.
    Yazici, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 984 - 984
  • [44] Analysis of Pain and Function Components in Omeract-Oarsi Strict Responders from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
    Strand, Vibeke
    Swearingen, Christopher J.
    Simsek, Ismail
    DiFrancesco, Anita
    Tambiah, Jeymi
    Yazici, Yusuf
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [45] LORECIVIVINT (SM04690), AN INTRA-ARTICULAR, SMALL-MOLECULE CLK/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, AS A POTENTIAL TREATMENT FOR MENISCAL INJURIES
    Seo, T.
    Deshmukh, V.
    Yazici, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1331 - 1331
  • [46] LORECIVIVINT (SM04690), AN INTRA-ARTICULAR, SMALL-MOLECULE CLK2/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, AS A POTENTIAL TREATMENT FOR MENISCAL INJURIES
    Seo, T.
    Deshmukh, V.
    Yazici, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 416 - 417
  • [47] LORECIVIVINT (SM04690), AN INTRA-ARTICULAR, SMALL-MOLECULE CLK/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, AS A POTENTIAL TREATMENT FOR MENISCAL INJURIES
    Seo, T.
    Deshmukh, V.
    Yazici, Y.
    OSTEOARTHRITIS AND CARTILAGE, 2021, 29 : S101 - S102
  • [48] LORECIVIVINT (SM04690), AN INTRA-ARTICULAR, SMALL-MOLECULE CLK/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, AS A POTENTIAL TREATMENT FOR MENISCAL INJURIES
    Seo, T.
    Deshmukh, V.
    Yazici, Y.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S595 - S596
  • [49] RADIOGRAPHIC OUTCOMES WERE ASSOCIATED WITH PAIN AND FUNCTION RESPONSES: POST-HOC ANALYSIS FROM A PHASE 2 STUDY OF A WNT PATHWAY INHIBITOR, SM04690, FOR KNEE OSTEOARTHRITIS TREATMENT
    Swearingen, C.
    Tambiah, J.
    Gibofsky, A.
    Lane, N.
    McAlindon, T.
    Hochberg, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 793 - 793
  • [50] OPTIMIZING SUBJECT SELECTION IN KNEE OSTEOARTHRITIS CLINICAL TRIALS BY RADIOGRAPHIC JOINT SPACE WIDTH: POST-HOC CLINICAL RESPONSE ANALYSIS FROM A PHASE 2B TRIAL OF WNT PATHWAY INHIBITOR, SM04690
    Kennedy, Sarah
    Swearingen, Christopher
    Tambiah, Jeyanesh
    Conaghan, Philip G.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 144 - 144